Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism METTL3 inhibitors(methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | - | 19 Mar 2024 | |
| Inflammation | Discovery | - | 19 Mar 2024 | |
| Neoplasms | Discovery | - | 19 Mar 2024 | |
| Nervous System Diseases | Discovery | - | 19 Mar 2024 |





